These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife? Converse PJ; Nuermberger EL; Almeida DV; Grosset JH Future Microbiol; 2011 Oct; 6(10):1185-98. PubMed ID: 22004037 [TBL] [Abstract][Full Text] [Related]
24. Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer. Almeida DV; Omansen TF; Li SY; Lee J; Grosset JH; Converse PJ; Nuermberger EL Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559131 [TBL] [Abstract][Full Text] [Related]
28. The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model. Liu Y; Gao Y; Liu J; Tan Y; Liu Z; Chhotaray C; Jiang H; Lu Z; Chiwala G; Wang S; Makafe G; Islam MM; Hameed HMA; Cai X; Wang C; Li X; Tan S; Zhang T Nat Commun; 2019 Jan; 10(1):524. PubMed ID: 30705268 [TBL] [Abstract][Full Text] [Related]
29. Effectiveness of rifampicin-streptomycin for treatment of Buruli ulcer: a systematic review. Tanywe A; Fernandez RS JBI Database System Rev Implement Rep; 2017 Jan; 15(1):119-139. PubMed ID: 28085731 [TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease. Sarfo FS; Phillips R; Asiedu K; Ampadu E; Bobi N; Adentwe E; Lartey A; Tetteh I; Wansbrough-Jones M Antimicrob Agents Chemother; 2010 Sep; 54(9):3678-85. PubMed ID: 20566765 [TBL] [Abstract][Full Text] [Related]
31. Pharmacologic management of Van Der Werf TS; Barogui YT; Converse PJ; Phillips RO; Stienstra Y Expert Rev Clin Pharmacol; 2020 Apr; 13(4):391-401. PubMed ID: 32310683 [TBL] [Abstract][Full Text] [Related]
32. Overview: Development of Drugs Against Mycobacterium ulcerans. Pluschke G; Röltgen K Methods Mol Biol; 2022; 2387():185-187. PubMed ID: 34643912 [TBL] [Abstract][Full Text] [Related]
33. On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer. Doig KD; Holt KE; Fyfe JA; Lavender CJ; Eddyani M; Portaels F; Yeboah-Manu D; Pluschke G; Seemann T; Stinear TP BMC Genomics; 2012 Jun; 13():258. PubMed ID: 22712622 [TBL] [Abstract][Full Text] [Related]
34. Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update. O'Brien DP; Jenkin G; Buntine J; Steffen CM; McDonald A; Horne S; Friedman ND; Athan E; Hughes A; Callan PP; Johnson PD Med J Aust; 2014 Mar; 200(5):267-70. PubMed ID: 24641151 [TBL] [Abstract][Full Text] [Related]
35. Painful Buruli ulcer in a Malian visitor to France. Ezzedine K; Pistone T; Guir V; Malvy D Acta Derm Venereol; 2010 Jul; 90(4):424. PubMed ID: 20574617 [No Abstract] [Full Text] [Related]